Kelly Timothy Edwin 4

What Happened Timothy E. Kelly, Chief Financial Officer of Praxis Precision Medicines (PRAX), acquired 121 shares on May 14, 2026 under the company Employee Stock Purchase Plan. The shares were acquired at $167.94 each for a total value of approximately $20,321. This was an acquisition (award/purchase), which is a purchase signal rather than a sale, though the amount is modest.

Key Details

• Transaction date: 2026-05-14; Price: $167.94 per share; Total value: ~$20,321
• Transaction type: Award/acquisition under Employee Stock Purchase Plan (ESPP)
• Footnote: Shares were acquired under the Praxis ESPP and were exempt under Rule 16b-3(d) and Rule 16b-3(c) (standard exemptions for plan purchases/awards).
• Shares owned after the transaction: Not stated in the provided filing.
• Filing: Form 4 filed 2026-05-19 for a 2026-05-14 transaction (filed 5 days after the transaction), which appears not to meet the usual two-business-day filing window.

Context This was an ESPP acquisition—common for employees and executives to buy company stock at a discount or through payroll deductions. Such purchases are routine and part of compensation/savings programs; they show personal participation in the company but do not, by themselves, indicate a change in company outlook.